These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19879959)

  • 1. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress.
    Yang HH; van Breemen C; Chung AW
    Vascul Pharmacol; 2010; 52(1-2):37-45. PubMed ID: 19879959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
    Chung AW; Yang HH; van Breemen C
    Br J Pharmacol; 2007 Oct; 152(3):305-12. PubMed ID: 17641673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
    Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome.
    Syyong HT; Chung AW; Yang HH; van Breemen C
    Br J Pharmacol; 2009 Nov; 158(6):1597-608. PubMed ID: 19814726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    Br J Pharmacol; 2009 Nov; 158(6):1503-12. PubMed ID: 19814725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
    Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
    Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Endothelial Barrier in Marfan Mice (mgR/mgR) Results in Severe Inflammation after Adenoviral Gene Therapy.
    Seppelt PC; Schwill S; Weymann A; Arif R; Weber A; Zaradzki M; Richter K; Ensminger S; Robinson PN; Wagner AH; Karck M; Kallenbach K
    PLoS One; 2016; 11(2):e0148012. PubMed ID: 26840980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
    Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
    Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Type-Specific Contributions of the Angiotensin II Type 1a Receptor to Aorta Homeostasis and Aneurysmal Disease-Brief Report.
    Galatioto J; Caescu CI; Hansen J; Cook JR; Miramontes I; Iyengar R; Ramirez F
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):588-591. PubMed ID: 29371244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.
    Judge DP; Biery NJ; Keene DR; Geubtner J; Myers L; Huso DL; Sakai LY; Dietz HC
    J Clin Invest; 2004 Jul; 114(2):172-81. PubMed ID: 15254584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical and pharmacological approaches to investigate the pathogenesis of Marfan syndrome in the abdominal aorta.
    Chung AW; Yang HH; Yeung KA; van Breemen C
    J Vasc Res; 2008; 45(4):314-22. PubMed ID: 18212506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm.
    Gibson C; Nielsen C; Alex R; Cooper K; Farney M; Gaufin D; Cui JZ; van Breemen C; Broderick TL; Vallejo-Elias J; Esfandiarei M
    J Appl Physiol (1985); 2017 Jul; 123(1):147-160. PubMed ID: 28385916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm.
    Nataatmadja M; West M; West J; Summers K; Walker P; Nagata M; Watanabe T
    Circulation; 2003 Sep; 108 Suppl 1():II329-34. PubMed ID: 12970255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.